[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study to evaluate the test preparation of PromacD orally disintegrating tablets and the reference preparation of PromacD orally disintegrating tablets in healthy adult subjects in the fasting/fed state
研究空腹/餐后状态下单次口服受试制剂聚普瑞锌口崩片与参比制剂聚普瑞锌口崩片(PromacD)在健康受试者体内的药代动力学,评价空腹/餐后状态口服两种制剂的生物等效性。研究受试制剂和参比制剂在健康受试者中的安全性。
[Translation] The pharmacokinetics of the test preparation, PromacD orally disintegrating zinc tablets, and the reference preparation, PromacD orally disintegrating zinc tablets (PromacD) were studied in healthy subjects after a single oral administration in the fasting/postprandial state, and the bioequivalence of the two preparations was evaluated after oral administration in the fasting/postprandial state. The safety of the test preparation and the reference preparation in healthy subjects was studied.